Cysteamine hydrochloride, a transglutaminase2 inhibitor as therapeutic potential for oral submucous fibrosis

• Main Authors: Basetty N Rajarathnam (Author), Nagaraju Rakesh (Author), Anita Murali (Author), J Anbu (Author), M L Asha (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Submucous fibrosis (SMF) was recognized as a definitive lesion by Schwartz who described it as a fibrosing condition in 1952 and due to its predilection for afflicting multiple sites in the oral cavity the disorder was listed as a "premalignant/precancerous condition". Tissue t...